Palomino Laboratories (PALX) Cash from Operations (2023 - 2025)
Palomino Laboratories (PALX) posted Cash from Operations of 343500.0 for Q3 2025, down 582.29% sequentially from 50345.0 in Q2 2025, and down 1189.47% YoY from 31529.0 in Q3 2024.
Palomino Laboratories (PALX) Cash from Operations (2023 - 2025) Analysis & Trends
Palomino Laboratories has reported Cash from Operations for 3 years, with the latest figure at 343500.0 in Q3 2025.
- Quarterly Cash from Operations fell 1189.47% year-over-year to 343500.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 558260.0 (changed N/A YoY) and the FY2024 annual result came in at 166637.0, down 109.93% from the prior year.
- Cash from Operations declined to 343500.0 in Q3 2025 per PALX's latest filing, from 50345.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 31529.0 in Q3 2024 and troughed at 343500.0 in Q3 2025.
- A 3-year average of 97249.5 and a median of 53555.5 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations plunged 195.01% in 2024, then slumped 1189.47% in 2025.
- Over 3 years, Cash from Operations stood at 56766.0 in 2023, then slumped by 195.01% to 167467.0 in 2024, then slumped by 105.12% to 343500.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 343500.0, 50345.0, and 3052.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -343,500.00 |
| Sep 30, 2025 | -343,500.00 |
| Jun 30, 2025 | -50,345.00 |
| Jun 30, 2025 | -50,345.00 |
| Mar 31, 2025 | 3,052.00 |
| Mar 31, 2025 | 3,052.00 |
| Dec 31, 2024 | -167,467.00 |
| Dec 31, 2024 | -167,467.00 |
| Sep 30, 2024 | 31,529.00 |
| Sep 30, 2024 | 31,529.00 |
| Dec 31, 2023 | -56,766.00 |
| Dec 31, 2023 | -56,766.00 |